In the News
January 7, 2021 | Duke Precision Genomics Collaboratory
How does a fish grow back scales?
How does a fish grow back scales it has lost to be the right size? Why don’t they just keep growing? The secret lies in waves of Erk activity.
January 4, 2021 | Duke Research Blog
Claire Engstrom, a Student Researcher Working to Treat Duchenne’s Muscular Dystrophy by Optimizing CRISPR-cas9
Claire first got involved with on-campus research through her pre-orientation program, PSearch.
December 1, 2020
CRISPR Tagging Improves Accuracy Of Model Cells Grown From Stem Cells
A team of biomedical engineers at Duke University has created a new way to turn stem cells into a desired cell type by mastering the language of gene regulatory networks.
November 12, 2020 | Duke Today
Astrocytes Identified as Master ‘Conductors’ of the Brain
Star-shaped ‘glue’ cells make it their business to govern connections between neurons
October 23, 2020 | Duke Today
Lab-grown Mini-lungs Mimic the Real Thing – Right Down to COVID Infection
Living human lung air sacs in tiny dishes promise to accelerate COVID research
October 22, 2020 | Duke School of Medicine
Transcription factors may inadvertently lock in DNA mistakes
Transcription factor proteins are the light switches of the human genome.
September 23, 2020
Diao receives $3 million grant from 4D Nucleome Consortium
Yarui Diao, Ph.D. received a U01 grant, totaling $3 million in research funding for 5 years, from 4D Nucleome Consortium (phase 2) through the NIH Common fund. Diao aims to determine the function and regulation of high-order chromatin structure on gene regulation and [...]
September 16, 2020 | Duke University
Lung Stem Cells in Transition - a Culprit in Lung Fibrosis
September 9, 2020
Diao awarded Genomic Innovator Awards
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, selected Yarui Diao to receive 2020 Genomic Innovator Awards. NHGRI honored a total of 12 early career investigators in genomics.
September 1, 2020 | Duke School of Medicine
Diao awarded 2020 Genomic Innovator Award
June 22, 2020 | Development
An interview with Ken Poss
Ken Poss recently joined the Development team as associate editor, focusing on the field of regenerative biology. Development interviewed him to find out more about his career, research, and why he decided to get involved with the journal.
June 19, 2020
Cancer: The wound that never heals
Yarui Diao is trying to shed more light on rhabdomyosarcoma in an effort to come up with better treatment options.
April 21, 2020 | Duke Research Blog
Asokan, Gersbach research highlighted by Vice President of Research
Dr. Carin reflects on how Duke's fundamental research can turn viruses into marvels.
March 31, 2020
Setting a trap for drug-resistant cancers
By Alissa Kocer A cancer patient and his family sit in a doctor’s office waiting to see how well he is responding to treatment. As the doctor pulls up his scans, all of the air in the room seems to vanish. When the doctor says, “Your tumor has shrunk and is almost gone!” A [...]
March 5, 2020
Four CAGT Faculty among MEDx Coloquia Award recipients
Four CAGT faculty are represented in the 2020 MEDxColloquia Awards. These colloquia are designed to bring together physicians, engineers, computer scientists, data analysts, and basic and/or clinical researchers with a desire to pursue an interdisciplinary approach to solve complex problems and inspire innovation in medicine.
February 28, 2020
Ciofani and Wood receive tenure
Center for Advanced Genomic Technologies Steering Committee Members Maria Ciofani and Kris Wood have recently been awarded tenure. Congratulations to you both!
January 2, 2020 | Duke Engineering News
Duke Researchers Garner Over $6 Million in NIH Funding to Fight Genetic Diseases
Collaborative work using CRISPR genome editing to address the burden of genetic neuromuscular diseases flourishes across Duke.
December 13, 2019 | Duke Engineering News
A Window into the Hidden World of Colons
Combining a skin-level glass window with a gut-stabilizing magnet, researchers get a view into the colon of a live animal
November 19, 2019
Greg Crawford and Charlie Gersbach Recognized as Highly Cited Researchers
Each year, the Web of Science Group identifies the world’s most influential researchers. The select few who have been most frequently cited by their peers over the last decade. In 2019, fewer than 6,300, or 0.1%, of the world's researchers, across 21 research fields, have [...]
November 15, 2019 | BioSpace
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, and StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies, will collaborate to develop in vivo AAV-based therapies for up to eight central nervous system and neuromuscular targets.
November 4, 2019 | Duke Engineering News
The Evolution of Genetic Engineering
A Q&A with Charles Gersbach
October 14, 2019 | Duke GCB News
Weapon of Mass Congestion: Protection from Influenza Virus through Gene Control
DARPA recently awarded a grant to a Duke team for a multifaceted research effort aimed at temporarily regulating gene expression using RNA-based techniques that could help protect against pandemic flu by boosting lung resistance to the virus, attacking the virus directly, enhancing the immune system response and improving the effects of existing vaccines.
September 30, 2019 | Duke Engineering News
New Duke Center Takes Aim at the Dark Genome
Spanning Duke University and Duke Health, the Center for Advanced Genomic Technologies will use homegrown tools and techniques to discover potential therapies for human diseases from autism to cancer to schizophrenia
September 23, 2019 | Duke Engineering News
New CRISPR Class Expands Genetic Engineering Toolbox
In a recent study, Charles Gersbach and Adrian Oliver, a post-doctoral fellow in the Gersbach lab who led the project, describe how they successfully harnessed Class 1 CRISPR systems to turn target genes on and off and edit the epigenome in human cells for the first time.